Canine Parainfluenza-Bordetella Bronchiseptica Vaccine
back to the BIVI product listing
Description
Canine Parainfluenza-Bordetella Bronchiseptica Vaccine. Naramune-2 is a modified live virus, avirulent live culture. Contains neomycin as a preservative.
Features
- Packaged 20 x 1 mL container or 1 x 5 dose vial.
- Intranasal administration.
- Variable reconstitution directions.
- Partial protection in 48 hours; complete protection in 72 hours.
- Administration in one or both nares.
- Nasal applicator tips included with every package.
- Rapid onset of immunity.
Benefits
- Easy-to-use. Variable dose volume.
- Safe to use in puppies as young as three weeks of age.
- Convenient intranasasal administration.
Advantages
Rapid, safe canine cough protection for puppies as young as three weeks of age. Intranasal application makes it convenient and easy-to-use.
Dosage & Administration
Using aseptic technique, rehydrate the freeze-dried vaccine to the desired dose volume with the accompanying sterile water diluent. Shake well and use at once. Do not vaccinate puppies under 3 weeks of age. Puppies vaccinated between 3 and 6 weeks of age should be revaccinated at 6 weeks. Annual revaccination is recommended.
Precautions
Store out of direct sunlight at a temperature not over 45∞ F (7∞ C). Use entire contents when first opened. Burn containers and all unused contents. Anaphylactoid reactions may occur.
Antidote: Epinephrine.
Antidote: Epinephrine.
Uses
Naramune-2 is recommended for vaccination of healthy, susceptible dogs and puppies against canine cough caused by canine parainfluenza and B bronchiseptica.
Warning
For intranasal use in dogs only. Do not vaccinate dogs parenterally.
Files
Ref PDF:
Label PDF:
MSDS PDF:
Additional Documents:
